BIOSYNTHETIC HUMAN INSULIN IN THE TREATMENT OF DIABETES-Reference-Cited by-同舟云学术

BIOSYNTHETIC HUMAN INSULIN IN THE TREATMENT OF DIABETES

Published:1982-08 Issue:8294 Volume:320 Page:354-357
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Clark AdrianJ.L,Knight Graham,Wiles PhilipG,Keen Harry,Ward JohnD,Cauldwell JoanM,Adeniyi-Jones RodneyO,Leiper JamesM,Jones RichardH,Maccuish AngusC,Watkins PeterJ,Glynne Alan,Scotton JanetB

Publisher

Elsevier BV

Subject

General Medicine

Reference13 articles.

1. Chemical, physical and biologic properties of biosynthetic human insulin;Chance;Diabetes Care,1981

2. Expression in Escherichia coli of chemically synthesised genes for human insulin;Goeddel;Proc Natl Acad Sci USA,1979

3. Symposium on biosynthetic human insulin;Skyler;Diabetes Care,1981

4. Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men;Keen;Lancet,1980

5. Pharmacokinetics of biosynthetic human insulin and characteristics of its effect;Botterman;Diabetes Care,1981

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Binding Promiscuity of Therapeutic Factor VIII;Thrombosis and Haemostasis;2024-07-01

2. Electrospinning technologies for the delivery of Biopharmaceuticals: Current status and future trends;International Journal of Pharmaceutics;2024-02

3. Guanidyl-Rich Poly(β Amino Ester)s for Universal Functional Cytosolic Protein Delivery and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Cas9 Ribonucleoprotein Based Gene Editing;ACS Nano;2023-09-05

4. Local Delivery Strategies for Peptides and Proteins into the CNS: Status Quo, Challenges, and Future Perspectives;Pharmaceuticals;2023-05-30

5. Reactive oxygen species-responsive branched poly (β-amino ester) with robust efficiency for cytosolic protein delivery;Acta Biomaterialia;2022-10